Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported) February 15, 2007


Interpharm Holdings, Inc.

(Exact name of Registrant as specified in charter)

Delaware
  
0-22710
  
13-3673965
(State or other jurisdic-
  
(Commission
  
(IRS Employer
tion of incorporation)
  
File Number)
  
Identification No.)
         
         
75 Adams Avenue, Hauppauge, New York
  
11788
(Address of principal executive offices)
  
(Zip Code)

Registrant's telephone number, including area code: (631) 952 0214 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On February 15, 2007, George Aronson, Interpharm Holdings, Inc.’s (the “Company”) Chief Financial Officer (“CFO”) resigned from his position as CFO to the Company. Mr. Aronson has agreed to continue as an employee of the Company during a transition period. Mr. Aronson has served as the Company’s CFO for three years and resigned to pursue other opportunities.


Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
INTERPHARM HOLDINGS, INC.
   
February 15, 2007
By:/s/ Kenneth Cappel, Esq.
 
       Kenneth Cappel, Esq.
 
       Executive Vice President and General Counsel